Hand–foot skin reaction as a positive prognostic factor in vascular endothelial growth factor receptor‐tyrosine kinase inhibitor treatment

Documenti analoghi

• Janus kinase inhibitors for the treatment of lichen Sclerosus: A systematic review
  di: Chin‐Hsuan Shen, et al.
  Pubblicazione: (2025)
• Renal‐vascular axis: unmasking its role in vascular endothelial growth factor‐inhibitor vascular toxicity in cancer patients
  di: Grace Whelan, et al.
  Pubblicazione: (2026)
• 7,4′‐dimethoxy‐3‐hydroxyflavone, a protease‐activated receptor 4 (PAR4) inhibitor with antioxidant activity, ameliorates diabetic endothelial dysfunction
  di: Ju‐Ying Tsai, et al.
  Pubblicazione: (2025)
• Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single‐agent fibroblast growth factor receptor‐specific inhibitors in pancreatic cancer
  di: Qingxiang Lin, et al.
  Pubblicazione: (2024)
• Bruton tyrosine kinase (Btk) in neutrophils is indispensable for initiating and maintaining skin inflammation in a model of pemphigoid diseases
  di: Henning Olbrich, et al.
  Pubblicazione: (2026)